CCL5 and neoplasm: The activation of the Wnt/β-catenin pathway by CTNNB1 mutations contributes to a decline in TIL by inducing downregulation of the chemokines CCL4 and CCL5 that attract dendritic cells and T cells into tumor tissue [15,16].